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O-002 How a dead duck can be fertile
Moeliker Kees1
1Natural History Museum Rotterdam, Rotterdam, The Netherlands
For witnessing and publishing ‘The first case of homosexual necrophilia in the 
mallard duck (Anas platyrhynchos)’ the speaker was awarded the 2003 Ig Nobel 
Prize in the field of Biology. Thanks to this much coveted award he became 
known as ´The Duck Guy´ and people from all over the globe send him their 
own observations of and/or publications on non-reproductive sexual behavior in 
animals. Here he presents highlights from his ever growing ‘Necrophilia Files’, 
including some severe cases that were overlooked for decades.
To address the topic of human reproduction too, the speaker will also share his 
insights in possibly the most dramatic example of current habitat destruction 
and loss of biodiversity – the disappearance of the once-ubiquitous crab louse 
(Pthirus pubis) due to excessive removal of pubic hair among sexually active 
people.
Keywords: ducks, animal behaviour, non-reproductive sexual behaviour, 
necrophilia, pubic louse
SELECTED ORAL COMMUNICATIONS
SESSION 02: NEW PERSPECTIVES ON EMBRYO SCORING
Monday 15 June 2015 10:00–11:30
O-003 Embryo quality scoring: a correlation between trophectoderm 
development and aneuploidy rate in developing blastocysts
J. Blazek1, M. Large1, V. Pham2, M. Hughes3, T. Gordon4
1Genesis Genetics, R&D/PGS, Houston, TX, U.S.A.
2Fertility Specialists of Houston, Embryology, Houston, TX, U.S.A.
3Genesis Genetics, PGS/PGD, Plymouth, MI, U.S.A.
4Genesis Genetics, PGS/PGD, London, United Kingdom
Study question: Blastocysts cultured for IVF are graded based on stage of 
hatching and organization of the inner cell mass and trophectoderm. Common 
practice is to implant embryos based on quality score in cases where preimplan-
tation genetic screening (PGS) is not used. Is blastocyst embryo quality score 
correlated with chromosomal ploidy?
Summary answer: PGS is critical to improving success rates in implantation 
and live birth during IVF. In cases where PGS is not used prior to implantation, 
embryo quality score can be used to determine the likelihood of embryo aneu-
ploidy based on strong correlations between embryo aneuploidy and in vitro 
trophectoderm development.
What is known already: It is common to select embryos for transfer based 
on morphology during IVF. A retrospective study assessing ploidy and gen-
eral blastocyst morphology suggests that blastocysts graded “excellent” have 
a higher euploid rate than embryos graded “good,” “average,” and “poor,” but 
the value of this information is limited to the general definitions of morphol-
ogy used. A better understanding of how ploidy effects blastocyst morphology 
and organization may help improve efficacy in non-PGS related IVF transfers.
Study design, size, duration: Embryo quality scores have been obtained for 
528 blastocysts from 112 patients all using the same IVF center. Trophectoderm 
biopsies from 528 blastocysts underwent PGS for chromosomal abnormalities 
using array CGH or Next Generation Sequencing and the results were com-
pared to embryo quality score to determine any existent correlations.
Participants/materials, setting, methods: Blastocyst stage embryos were 
scored according to the standard Gardner blastocyst grading system by a single 
embryologist. Amplified trophectoderm biopsies were analyzed using either 
Illumina’s 24-sure array CGH or VeriSeq NGS protocols and chromosomal 
 profiles were compared to embryo score to determine correlates.
INVITED SESSION
SESSION 01: ROBERT G. EDWARDS’ MEMORIAL KEYNOTE SESSION
Monday 15 June 2015 08:30–09:30
O-001 Human reproduction keynote lecture – preconception stress 
increases the risk of infertility: results from a couple-based prospective 
cohort study, the LIFE study
C. D. Lynch1, R. Sundaram2, J. M. Maisog2, A. M. Sweeney3, G. M. Buck 
Louis2
1The Ohio State University College of Medicine, Department of Obstetrics and 
Gynecology, Columbus, U.S.A.
2Eunice Kennedy Shriver National Institute of Child Health and Human 
Development, Division of Intramural Population Health Research, Rockville, 
U.S.A.
3Texas A&M Health Science Center, Department of Epidemiology and Biosta-
tistics, College Station, U.S.A.
Study question: Are women’s stress levels prospectively associated with fecun-
dity and infertility?
Summary answer: Higher levels of stress as measured by salivary alpha-am-
ylase are associated with a longer time-to-pregnancy (TTP) and an increased 
risk of infertility.
What is known already: Data suggest that stress and reproduction are inter-
related; however, the directionality of that association is unclear.
Study design, size, duration: In 2005–2009, we enrolled 501 couples precon-
ceptionally in a prospective cohort study in Michigan and Texas, USA. Couples 
were followed for up to 12 months and through pregnancy if it occurred. A total 
of 401 (80%) couples completed the study and 373 (93%) had complete data 
available for this analysis.
Participants/materials, setting, methods: Enrolled women collected saliva 
the morning following enrollment and then the morning following their first 
observed study menses for the measurement of cortisol and alpha-amylase, 
which are biomarkers of stress. TTP was measured in cycles. Covariate data 
were captured on both a baseline questionnaire and daily journals.
Main results and the role of chance: Among the 401 (80%) women who com-
pleted the protocol, 347 (87%) became pregnant and 54 (13%) did not. After 
adjustment for female age, race, income, and use of alcohol, caffeine, and ciga-
rettes while trying to conceive, women in the highest tertile of alpha-amylase 
exhibited a 29% reduction in fecundity (longer TTP) compared with women 
in the lowest tertile [fecundability odds ratio = 0.71; 95% confidence interval 
(CI) = (0.51, 1.00); p < 0.05]. This reduction in fecundity translated into a more 
than twofold increased risk of infertility among women these women [Relative 
Risk = 2.07; 95% CI = (1.04, 4.11)]. In contrast, we found no association be-
tween salivary cortisol and fecundability.
Limitations, reasons for caution: Due to fiscal and logistical concerns, we 
were unable to collect repeated saliva samples and perceived stress question-
naire data throughout the duration of follow-up. Therefore, we were unable 
to examine whether stress levels increased as women continued to fail to get 
pregnant.
Wider implications of the findings: This is the first US study to demonstrate 
a prospective association between salivary stress biomarkers and TTP, and the 
first in the world to observe an association with infertility.
Study funding/competing interest(s): This study was supported by the In-
tramural Research Program of the Eunice Kennedy Shriver National Insti-
tute of Child Health and Human Development (contracts #N01-HD-3-3355, 
N01-HD-3-3356, N01-HD-3358). There are no conflicts of interest to 
declare .
Trial registration number: NA.
Keywords: fecundity, infertility, stress
ORAL PRESENTATIONS
ABSTRACTS OF THE 31ST ANNUAL MEETING OF ESHRE I LISBON, PORTUGAL – 14 to 17 June, 2015
Downloaded from https://academic.oup.com/humrep/article-abstract/30/suppl_1/i1/647553
by guest
on 22 August 2018
i136
Abstracts of the 31st Annual Meeting of ESHRE, Lisbon, Portugal, 14 June – 17 June, 2015
Study question: This study aims’ at investigating the relationship between sem-
inal plasma growths factors (TGF β1, IGF I and EGF) and semen parameters, 
sperm DNA fragmentation, and ART outcome among idiopathic infertile men 
and normal men.
Summary answer: The increase of Seminal TGFβ1 levels was significantly as-
sociated with low semen characteristics such as total sperm count, progressive 
motility and normal morphology, and with high rate of sperm DNA fragmenta-
tion in idiopathic infertile men. Nevertheless, we didn’t found any correlation 
between growth factors and IVF or ICSI outcomes.
What is known already: It is becoming apparent that seminal growth factors 
have a definite role in fertility and their modulation can cause infertility in both 
men and women. These factors have also been shown to have both positive and 
negative effects on the function of spermatozoa in vitro. Therefore, their explo-
ration may provide useful information in cases of male idiopathic infertility.
Study design, size, duration: A prospective study conducted during one year 
that included 104 couples undergoing ART cycles (IVF or ICSI). Two groups 
were identified according to semen analysis and infertility related factor. A first 
group (n = 67) with only male infertility factor (idiopathic OAT) and a control 
group (n = 37) with normal semen parameters.
Participants/materials, setting, methods: A part of each sample was prepared 
using a discontinuous sperm gradient after parameters analyze, for oocyte 
insemination or injection and the remaining pellet was fixed for subsequent 
measure of DNA fragmentation index (TUNEL assay).Subsequently, seminal 
plasma growth factors concentrations were measured by ELISA using com-
mercially available kits.
Main results and the role of chance: The mean concentration of seminal 
plasma TGF β1 was significantly higher in OAT group 234.68 ± 41.32 vs. 
97.25 ± 36.85 ng/ml in controls (p = 0.001). TGF β1 levels were correlated 
negatively with sperm total count, motility (r = -0.437, p = 0.000; r = -0.556, 
p = 0.000) but positively with teratozoospermia (r = 0.705; p = 0.000). No 
evident correlation was found between these growth factors and ART outcomes 
such as fertilization, cleavage, top embryos and pregnancy rates. Idiopathic 
infertile men showed a high degree of DNA damage20.21% as compared to 
controls 12.96% (p = 0.02). A strong significant negative correlation was found 
between DNA fragmentation and all semen parameters (p < 0.01). Moreover, a 
significant positive correlation was noted between seminal TGF β1 and sperm 
DNA fragmentation levels (r = 0.350, p = 0.01) but not with IVF or ICSI 
outcomes.
Limitations, reason for caution: EGF tented to be higher in OAT group but the 
difference was not significant. EGF levels were lower among patients with clini-
cal pregnancy compared to those with ART failure but IGFI levels were higher 
in controls and in cases of pregnancy. This may due to our small sample size.
Wider implications of the findings: Seminal TGFβ1 may have a direct or 
indirect role in spermatogenesis-steroidogenesis and its derangement may be 
involved in male idiopathic infertility especially when mediated through low 
semen characteristics and high DFI which can be explained by reactive oxygen 
species (ROS) generated with excessive seminal TGFβ1 that leads to DNA dis-
integration and therefore to increase sperm DNA damage. However, the exact 
molecular mechanism of seminal TGF β1on spermatic cells inducing ROS pro-
duction requires further investigation.
Study funding/competing interest(s): Funding by hospital/clinic(s) – Univer-
sity Farhat Hachad Hospital-unit of reproductive medicine.
Trial registration number: NA.
Keywords: growth factors, semen parameters, DNA fragmentation, ART 
outcome
P-029 Efficacy of follicle-stimulating hormone treatment in male 
idiopathic infertility: a meta-analysis
D. Santi1, A. R. M. Granata1, M. Simoni1
1Unit of Endocrinology, Department of Biomedical Metabolic and Neural  
Sciences University of Modena and Reggio Emilia Italy, Modena, Italy
Study question: To comprehensively evaluate whether follicle stimulating hor-
mone (FSH) administration to the male partner of idiopathic infertile couples 
improves pregnancy rate, both spontaneous and after assisted reproductive tech-
nique (ART), using a meta-analytic approach and including controlled clinical 
trial.
Summary answer: The administration of FSH to infertile men is reported in the 
literature since 1991, improving fertilisation and pregnancy rate. A significant 
increase in pregnancy rate after ART and male treatment with FSH was already 
shown in several studies, since FSH improves the sperm quality. FSH treatment 
could improve sperm quality and pregnancy rate in idiopathic infertile men.
What is known already: The Cochrane Collaboration recently estimated the 
overall effect of FSH treatment of the man in couples attending ART, enrolled 
in randomised, controlled, clinical-trials. That meta-analysis demonstrated that 
FSH treatment significantly improves spontaneous pregnancy rate, whereas no 
improvement of pregnancy rate was observed after ART, using fixed and strict 
inclusion criteria. They excluded all trials in which the randomization was not 
provided leading to potential loss of useful information that could help clini-
cians in their routinely practice.
Study design, size, duration: We conducted a comprehensive literature search 
for controlled clinical trials in which FSH was administered for male idiopathic 
infertility, compared with placebo or no treatment. The randomization was not 
considered as inclusion criterion. We considered studies in which men with 
idiopathic infertility or subfertility were enrolled, chronicallty treated with any 
type of FSH, compared with placebo or no treatment.
Participants/materials, setting, methods: We found 15 controlled clinical stud-
ies. Concerning the type of FSH, eight studies included in the meta-analysis 
used recombinant FSH, whereas seven studies used purified FSH. Pregnancy 
rate, when evaluated, was considered spontaneous or after ART. Selected trials 
gave details about 1275 infertile-men, 614 treated with FSH and 661 not-treated.
Main results and the role of chance: Among the 15 studies included, nine 
studies evaluated the spontaneous pregnancy rate, resulting in an overall im-
provement of about 4.5 (CI 2.17–9.33 and I2 = 0%) (p < 0.001). Eight stud-
ies evaluated pregnancy rate after ART, showing a significant improvement of 
about 1.60 (CI 1.08–2.37 and I2 = 43%) (p = 0.002). Sub-dividing studies ac-
cording to the FSH preparations (purified or recombinant), the pregnancy rate 
improvement remained significant (p = 0.007 and p = 0.002, respectively). Elev-
en studies considered sperm quality after FSH treatment, finding a significant 
improvement of sperm concentration (mean improvement of 2.66x106 millions/
mL, with CI 0.47–4.84, p = 0.02), but not of sperm motility (mean improvement 
of 1.22x106 millions/mL, with CI -0.07–2.52, p = 0.06). Finally, three trials 
evaluated testicular volume, showing a non-significant increase in men treated 
(mean increase of 1.35 mL, with CI -0.44–3.14, p = 0,14).
Limitations, reason for caution: The heterogeneity of studies, together with 
the high risk of biases in this field of research could limit the strength of these 
results.
Wider implications of the findings: The results of controlled clinical trials 
available in literature indicate an improvement of pregnancy rate after FSH ad-
ministration to the male partner of infertile couples, both spontaneous and after 
ART.
Study funding/competing interest(s): Funding by University(ies) – University 
of Modena and Reggio Emilia.
Trial registration number: NA.
Keywords: FSH, idiopathic male infertility, reproduction
P-030 Are obese men subfertile?
S. Alshahrani1, A. Gabr1, A. Ahmed1
1Salman Bin Abdulaziz University, Surgery, Riaydh, Saudi Arabia
Study question: Does obesity affects male fertility potentials?
Summary answer: BMI was proved, in our study, to have a significant effect 
on sperm concentration.
What is known already: Overweight and obesity can affect female fertility, in 
men the negative effects on reproductive system attributed to obesity are less 
evident and have been less often studied.
Study design, size, duration: Prospective, 439 male partners of couples present-
ing for evaluation of infertility, in the period from January 2013 to November 2014.
Participants/materials, setting, methods: Semen samples from 439 male 
partners of couples presenting for evaluation of their infertility, were collected. 
Men were divided into three BMI groups; normal, overweight and obese. Sam-
ples has been analyzed based on the WHO 5th edition guidelines. Meticulous 
scrotal examination and scrotal ultrasound were performed. Hormonal profile, 
including testosterone, FSH, LH and prolactin was done to exclude any possible 
causative hormonal factor.
Main results and the role of chance: Mean BMI was 29.67 ± 5.89. ANOVA 
testing revealed no significant differences in semen parameters between the 3 
different BMI groups. Also, pair-wise multiple comparisons were found to be 
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